Drawing for REVRAMCEO

USPTO serial 50202738

REVRAMCEO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with REVRAMCEO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Phillip Barengolts

Phillip Barengolts Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP125 S. Wacker DriveSuite 2050Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of oncological diseases, disorders and deficiencies; pharmaceutical preparations for the prevention and treatment of cardiological diseases, disorders and deficiencies; pharmaceutical preparations for the prevention and treatment of inflammatory diseases, disorders and deficiencies; pharmaceutical preparations for the treatment of genetically predisposed diseases, disorders and deficiencies; pharmaceutical preparations for the prevention and treatment of diseases, disorders and deficiencies affecting the central nervous system; pharmaceutical preparations for the treatment of Parkinson's disease, movement, neuromuscular, neurological, neurodegenerative, cognitive and brain diseases, disorders and deficienciesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 5, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 5, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance